Profund Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-57,295
| Closed | -$10.5M | – | 1473 |
|
|
2021
Q2 | $10.5M | Sell |
57,295
-1,327
| -2% | -$228K | 0.35% | 47 |
|
|
2021
Q1 | $8.96M | Sell |
58,622
-1,278
| -2% | -$198K | 0.34% | 49 |
|
|
2020
Q4 | $9.36M | Buy |
59,900
+4,503
| +8% | +$579K | 0.41% | 39 |
|
|
2020
Q3 | $6.34M | Sell |
55,397
-7,815
| -12% | -$843K | 0.33% | 52 |
|
|
2020
Q2 | $7.09M | Buy |
63,212
+7,729
| +14% | +$821K | 0.39% | 38 |
|
|
2020
Q1 | $4.98M | Sell |
55,483
-18,540
| -25% | -$1.82M | 0.37% | 45 |
|
|
2019
Q4 | $8.01M | Buy |
74,023
+6,624
| +10% | +$708K | 0.35% | 48 |
|
|
2019
Q3 | $6.6M | Sell |
67,399
-3,795
| -5% | -$428K | 0.33% | 46 |
|
|
2019
Q2 | $9.32M | Sell |
71,194
-5,476
| -7% | -$706K | 0.44% | 35 |
|
|
2019
Q1 | $10.4M | Buy |
76,670
+1,355
| +2% | +$168K | 0.5% | 30 |
|
|
2018
Q4 | $7.33M | Sell |
75,315
-18,003
| -19% | -$2.13M | 0.45% | 36 |
|
|
2018
Q3 | $13M | Buy |
93,318
+8,387
| +10% | +$1.05M | 0.49% | 30 |
|
|
2018
Q2 | $10.5M | Sell |
84,931
-4,240
| -5% | -$496K | 0.42% | 35 |
|
|
2018
Q1 | $9.94M | Sell |
89,171
-7,626
| -8% | -$912K | 0.4% | 39 |
|
|
2017
Q4 | $11.6M | Sell |
96,797
-10,447
| -10% | -$1.27M | 0.45% | 36 |
|
|
2017
Q3 | $15M | Buy |
107,244
+6,706
| +7% | +$911K | 0.63% | 22 |
|
|
2017
Q2 | $12.2M | Sell |
100,538
-5,706
| -5% | -$664K | 0.55% | 26 |
|
|
2017
Q1 | $12.9M | Sell |
106,244
-6,904
| -6% | -$890K | 0.58% | 25 |
|
|
2016
Q4 | $13.8M | Sell |
113,148
-15,851
| -12% | -$1.94M | 0.64% | 24 |
|
|
2016
Q3 | $15.8M | Sell |
128,999
-5,067
| -4% | -$652K | 0.75% | 17 |
|
|
2016
Q2 | $15.7M | Sell |
134,066
-7,447
| -5% | -$1.06M | 0.76% | 18 |
|
|
2016
Q1 | $19.7M | Sell |
141,513
-32,550
| -19% | -$4.78M | 1.02% | 13 |
|
|
2015
Q4 | $33.2M | Buy |
174,063
+93
| +0.1% | +$16.2K | 1.58% | 10 |
|
|
2015
Q3 | $27.2M | Sell |
173,970
-7,217
| -4% | -$1.32M | 1.55% | 9 |
|
|
2015
Q2 | $32.8M | Buy |
181,187
+14,657
| +9% | +$2.53M | 1.36% | 9 |
|
|
2015
Q1 | $28.9M | Buy |
166,530
+11,436
| +7% | +$2.07M | 1.12% | 11 |
|
|
2014
Q4 | $28.7M | Buy |
155,094
+15,662
| +11% | +$2.9M | 1.17% | 11 |
|
|
2014
Q3 | $23.1M | Buy |
139,432
+9,630
| +7% | +$1.58M | 1.08% | 12 |
|
|
2014
Q2 | $20.3M | Sell |
129,802
-32,278
| -20% | -$5.1M | 0.89% | 12 |
|
|
2014
Q1 | $24.7M | Buy |
162,080
+29,066
| +22% | +$4.62M | 1.12% | 11 |
|
|
2013
Q4 | $17.7M | Buy |
133,014
+26,431
| +25% | +$3.17M | 0.79% | 12 |
|
|
2013
Q3 | $12.4M | Buy |
106,583
+5,339
| +5% | +$586K | 0.66% | 15 |
|
|
2013
Q2 | $9.34M | Buy |
+101,244
| New | +$9.76M | 0.66% | 18 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM